This book presents the current evidence and practice in the pharmacological treatment of atrial fibrillation (AF). AF management has changed significantly in recent years as a new era has begun for the prevention of stroke, one of the most devastating complications of AF. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge and the enormous amount of research is revealing new treatment opportunities at a dizzying pace.While new classes of antithrombotic drugs for AF treatment are still in their infancy, recent research is revealing how these can be applied with optimal efficacy. Atrial Fibrillation Therapy includes practical information for readers on applying the guidelines developed as a result of the increased pharmacotherapeutic understanding. This book also guides trainees, recertifying physicians, and practicing physicians in internal medicine, cardiology, emergency medicine, and clinical pharmacology to apply the new diagnostic tools for selecting the best treatment options for AF patients.
TABLE OF CONTENTS
Epidemiology, burden and unmet needs in atrial fibrillation.- Inside Molecular Mechanisms and pharmacological Targets of Atrial Fibrillation.- Novel oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.- Upstream therapy in the treatment of atrial fibrillation.- Drug therapy for rhythm and rate control in Atrial Fibrillation.- Changing the paradigm to understand and manage Atrial Fibrillation.- Guidelines and current recommendations in Atrial Fibrillation.
DETTAGLI PRODOTTO torna su
Titolo: Atrial Fibrillation Therapy
Autori: Dan - Bayes de Luna - Camm
Editore: Springer Verlag
Collana: Current Cardiovascular Therapy
Finitura: Copertina flessibile